DL-VSU-201 is a randomized, double-blind, placebo-controlled study in subjects with a non-infected venous stasis ulcer (VSU) that has failed to demonstrate imp…

Venous Stasis UlcerVenous Leg Ulcer

~Estimated

~$10 – $8,750

Merakris TherapeuticsNCT04647240

Phase 3

A Phase 3 Randomized, Parallel Group, Double-Blind Study to Evaluate the Efficacy, Tolerability, and Safety of TR987® 0.1% Gel Versus Standard of Care in the Treatment of Chronic Venous Insufficiency Leg Ulcers (VLU)

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It…

Venous Leg UlcerVenous UlcerVenous Stasis Ulcer+5 more

~Estimated

~$10 – $8,750

TR TherapeuticsNCT06707103

Phase 3

A Phase 3 Randomized, Parallel Group, Double-Blind Study to Evaluate the Efficacy, Tolerability, and Safety of TR987® 0.1% Gel Versus Standard of Care in the Treatment of Chronic Venous Insufficiency Leg Ulcers (VLU)

The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It…

Venous Leg UlcerVenous UlcerVenous Stasis Ulcer+5 more

~Estimated

~$10 – $8,750

TR TherapeuticsNCT06707090